Modulation of apoptosis by sulindac, curcumin, phenylethyl-3- methylcaffeate, and 6-phenylhexyl isothiocyanate: Apoptotic index as a biomarker in colon cancer chemoprevention and promotion

Cancer Research

Volumn 57, Issue 7, 1997, Pages 1301-1305

  Samaha, Hanan S ^a   Kelloff, Gary J ^b   Steele, Vernon ^b   Rao, Chinthalapally V ^a   Reddy, Bandaru S ^a,b  

^a AMERICAN HEALTH FOUNDATION   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAFFEIC ACID DERIVATIVE; CURCUMIN; PHENYLETHYL 3 METHYLCAFFEATE; SULINDAC; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER PREVENTION; CHEMOPROPHYLAXIS; COLON CANCER; COLON CARCINOGENESIS; CONTROLLED STUDY; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT;

ADENOCARCINOMA; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTICARCINOGENIC AGENTS; APOPTOSIS; AZOXYMETHANE; CAFFEIC ACIDS; CARCINOGENS; COLONIC NEOPLASMS; CURCUMIN; ISOTHIOCYANATES; MALE; RATS; RATS, INBRED F344; SULINDAC; TUMOR MARKERS, BIOLOGICAL;

EID: 0031000902     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Parker, S. L., Tong, T., Bolden, S., and Wingo, P. A. Cancer statistics. CA Cancer J. Clin., 65: 5-27, 1996.
2. Boone, C. W., Kelloff, G. J., and Malone, W. F. Identification of candidate cancer chemopreventive agents and their evaluation in animal models and human clinical trials: a review. Cancer Res., 50: 2-9, 1990.
3. Greenwald, P., and Kelloff, G. J. The role of chemoprevention in cancer control. In: B. W. Stewart, D. McGregor, and P. Kleihus (eds.), Principles of Chemoprevention, pp. 13-22. IARC Scientific Publ. No. 139. Lyon, France: IARC, 1996.
4. Rao, C. V., Desai, D., Rivenson, A., Simi, B., Amin, S., and Reddy, B. S. Chemoprevention of colon carcinogenesis by phenylethyl-3-methylcaffeate. Cancer Res., 55: 2310-2315, 1995.
5. Rao, C. V., Rivenson, A., Simi, B., and Reddy, B. S. Chemoprevention of colon carcinogenesis by dietary curcumin, a naturally occurring plant phenolic compound. Cancer Res., 55: 259-266, 1995.
6. Rao, C. V., Rivenson, A., Simi, B., Zang, E., Kelloff, G., Steele, V., and Reddy, B. S. Chemoprevention of colon carcinogenesis by sulindac, a nonsteroidal anti-inflammatory agent. Cancer Res., 55: 1464-1472, 1995.
7. Thun, M. H., Namboodiri, M. M., and Heath, C. W. Aspirin use and reduced risk of fatal colon cancer. N. Engl. J. Med., 325: 1593-1596, 1991.
8. Giardiello, F. M., Hamilton, S. R., Krush, A. J., Piantadosi, S., Hylind, L. M., Celano, P., Booker, S. V., Robinson, C. R., and Offerhaus, G. J. Treatment of colonie and rectal adenomas with sulindac in familial adenomatous polyposis. N. Engl. J. Med., 328: 1313-1316, 1993.
9. Thorson, A. G., Lynch, H. T., and Smyrk, T. C. Rectal cancer in FAP patients after sulindac. Lancet, 343: 180, 1994.
10. Moorghen, M., Ince, P., Finney, K. J., Sunter, J. P., Appleton, D. R., and Watson, A. J. A protective effect of sulindac against chemically induced primary colonie tumors in mice. J. Pathol., 156: 341-347, 1988.
11. Satoskar, R. R., Shah, S. J., and Shenoy, S. G. Evaluation of anti-inflammatory property of curcumin (diferuloyl methane) in patients with postoperative inflammation. Int. J. Clin. Pharmacol. Ther. Toxicol., 24: 651-654, 1986.
12. Toda, S., Miyase, T., Arichi, H., Tanizawa, H., and Takino, Y. Natural antioxidant III. Antioxidative components isolated from rhizome of Curcuma longa L. Chem. & Pharm. Bull (Tokyo), 33: 1725-1728, 1985.
13. Rao, C. V., Simi, B., and Reddy, B. S. Inhibition by dietary curcumin of azoxymethane-induced ornithine decarboxylase, tyrosine protein kinase, arachidonic acid metabolism, and aberrant crypt foci formation in the rat colon. Carcinogenesis (Lond.), 14: 2219-2225, 1993.
14. Azuine, M. A., and Bhide, S. V. Chemopreventive effect of turmeric against stomach and skin tumors induced by chemical carcinogens in Swiss mice. Nutr. Cancer, 17: 77-83, 1992.
15. Huang, M. T., Ma, W., Lou, Y-R., Ferraro, T., Reuhl, K., Newmark, H., and Conney, A. H. Inhibitory effect of dietary curcumin on gastrointestinal tumorigenesis in mice. Proc. Am. Assoc. Cancer Res., 34: 555, 1993.
16. Jeddar, A., Kharsany, A., Ramsaroop, V. G., Bhamjee, A., Haffejee, I. E., and Moosa, A. The antibacterial action of honey, an in vitro study. S. Afr. Med J., 67: 257-258, 1985.
17. Koshihara, Y., Neichi, T., Murota, S. L., Lao, A., Fujimoti, Y., and Tatsuno, T. Caffeic acid is a selective inhibitor for leukotriene biosynthesis. Biochim. Biophys. Acta, 792: 92-97, 1984.
18. Rao, C. V., Desai, D., Kaul, B., Amin, S., and Reddy, B. S. Effect of caffeic acid esters on carcinogen-induced mutagenicity and human colon adenocarcinoma cell growth. Chem. Biol. Interact., 84: 277-290, 1992.
19. Grunberger, D., Banerjee, R., Eisinger, K., Oltz, E. M., Efros, L., Caldwell, M., Estevez, V., and Nakanishi, K. Preferential cytotoxicity on tumor cells by caffeic acid phenethyl ester isolated from propolis. Experientia (Basel), 44: 230-232, 1988.
20. Morse, M. A., Eklind, K. I., Hecht, S. S., Jordan, K. G., Choi, C-I., Desai, D. H., Amin, S. G., and Chung, F-L. Structure-activity relationships for inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone lung tumorigenesis by arylalkylisothiocyanates in A/J mice. Cancer Res., 51: 1846-1850, 1991.
21. Sugie, S., Okamoto, K., Okumura, A., Tanaka, T., and Mori, H. Inhibitory effects of benzyl thiocyanate and benzyl isothiocyanate on methylazoxymethanol acetate-induced intestinal carcinogenesis in rats. Carcinogenesis (Lond.), 15: 1550-1560, 1994.
22. Rao, C. V., Rivenson, A., Simi, B., Zang, E., Hamid, R., Kelloff, G., Steele, V., and Reddy, B. S. Enhancement of experimental colon carcinogenesis by dietary 6-phenylhexyl isothiocyanate. Cancer Res., 55: 4311-4318, 1995.
23. Dunnick, J., Prejean, J. D., Haseman, J., Thompson, R. B., Giles, H. D., and McConnell, E. Carcinogenesis bioassay of allyl isothiocyanate. Fundam. Appl. Toxicol., 2: 114-120, 1982.
24. Lin, J-M., Amin, S., Trushin, N., and Hecht, S. S. Effect of isothiocyanates on tumorigenesis by benzo(a)pyrene in murine tumor models. Cancer Lett., 74: 151-159, 1993.
25. Pasricha, P. J., Bedi, A., O'Connor, K., Rashid, A., Akhtar, A. J., Zahurak, M. L., Piantadosi, S., Hamilton, S. R., and Giardiello, F. M. The effects of sulindac on colorectal proliferation and apoptosis in familial adenomatous polyposis. Gastroenterology, 109: 994-998, 1995.
26. Boolbol, S. K., Dannenberg, A. J., Chadburn, A., Martucci, C., Guo, X-J., Ramonetti, J. T., Abreu-Goris, M., Newmark, H. L., Lipkin, M. L., DeCosse, J. J., and Bertagnolli, M. M. Cyclooxygenase-2 overexpression and tumor formation are blocked by sulindac in a murine model of familial adenomatous polyposis. Cancer Res., 56: 2556-2560, 1996.
27. Elder, D. J. E., Hague, A., Hicks, D. J., and Paraskeva, C. Differential growth inhibition by the aspirin metabolite salicylate in human colorectal tumor cell lines: enhanced apoptosis in carcinoma and in vitro-transformed adenoma relative to adenoma cell lines. Cancer Res., 56: 2273-2276, 1996.
28. Wright, S. C., Zhong, J., Zheng, H., and Larrick, J. W. Nicotine inhibition of apoptosis suggests a role in tumor promotion. FASEB J., 7: 1045-1051, 1993.
29. Samaha, H. S., Bernstein, C., Payne, C. M., Garewal, S., Sampliner, R. E., and Bernstein, H. Bile salt induction of apoptosis in goblet cells of the normal human colonic mucosa: relevance to colon cancer. Acta Microscopica, 4(Suppl. 1): 43-58, 1995.
30. Dive, C., and Hickmann, J. A. Drug-target interactions: only the first step in the commitment to a programmed cell death? Br. J. Cancer, 64: 192-196, 1991.
31. Bedi, A., Pasricha, P. J., Akhtar, A. J., Barber, J. P., Bedi, G. C., Giardiello, F. M., Zehnbauer, B. A., Hamilton, S. R., and Jones, R. J. Inhibition of apoptosis during development of colorectal cancer. Cancer Res., 55: 1464-1472, 1995.
32. Russell, J. H. Internal disintegration model of cytotoxic lymphocyte-induced target damage. Immunol. Rev., 72: 97-118, 1983.
33. Wyllie, A. H., Kerr, J. F. R., and Currie, A. R. Cell death: the significance of apoptosis. Int. Rev. Cytol., 68: 251-306, 1980.
34. Elwell, M. R., and McConnell, E. E. Small and large intestine. In: G. A. Boorman, S. L. Eustis, M. R. Elwell, C. A. Montgomery, Jr., and W. F. MacKenzie (eds.), Pathology of the Fisher Rat, pp. 43-61. New York: Academic Press, Inc., 1990.
35. Wheeldon, E. B., Williams, S. M., Soames, A. R., James, N. H., and Roberts, R. A. Quantitation of apoptotic bodies in rat liver by in situ end-labeling (ISEL): correlation with morphology. Toxicol. Pathol. 23(Suppl. 3): 410-415, 1995.
36. Samaha, H. S., Asher, E., Payne, C. M., Bernstein, C., and Bernstein, H. Evaluation of cell death in EBV-transformed lymphocytes using agarose gel electrophoresis, light microscopy, and electron microscopy. I. Induction of classic apoptosis by the bile salt, sodium deoxycholatc. Leuk. & Lymphoma, 19: 95-105, 1995.
37. Russell, S. W., Rosenau, W., and Lee, J. C. Cytolysis induced by human lymphotoxin B. Cinemicrographic and electron microscopic observations. Am. J. Pathol., 69: 103-118, 1972.
38. Cohen, J. J., and Duke, R. C. Glucocorticoid activation of a calcium-dependent endonuclease in thymocyte nuclei leads to cell death. J. Immunol., 132: 38-42, 1984.
39. Falcieri, E., Martelli, A. M., Bareggi, R., Cataldi, A., and Cocco, L. The protein kinase inhibitor staurosporine induces morphological changes typical of apoptosis in Molt-4 cells without concomitant DNA fragmentation. Biochem. Biophys. Res. Commun., 193: 19-25, 1993.
40. Cohen, G. M., Sun, X-M., Snowden, R. T., Dinsdale, D., and Skilleter, D. N. Key morphological features of apoptosis may occur in the absence of internucleosomal DNA fragmentation. Biochem. J., 286: 331-334, 1992.
41. Collins, R. J., Harmon, B. V., Gobe, G. C., and Kerr, J. F. R. Internucleosomal DNA cleavage should not be the sole criterion for identifying apoptosis. Int. J. Radiat. Biol., 61: 451-453, 1992.
42. Fukuda, K., Kojio, M., and Chiu, J-F. Demonstration of extensive chromatin cleavage in transplanted Morris hepatoma 7777 tissue: apoptosis or necrosis? Am. J. Pathol., 142: 935-946, 1993.
43. Su, Z-Z., Lin, J., Prewett, M., Goldstein, N. I., and Fisher, P. B. Apoptosis mediates the selective toxicity of caffeic acid phenethyl ester (CAPE) toward oncogene-transformed rat embryo fibroblast cells. Anticancer Res., 15: 1841-1848, 1995.
44. Chiao, C., Carothers, A. M., Grunberger, D., Solomon, G., Preston, G. A., and Barrett, J. C. Apoptosis and altered redox state induced by caffeic acid phenethyl ester (CAPE) in transformed rat fibroblast cells. Cancer Res., 55: 3576-3583, 1995.
45. Schiff, S. J., Qiao, L., Tsai, L-L., and Rigas, B. Sulindac sulfide, an aspirin-like compound, inhibits proliferation, causes cell cycle quiescence, and induces apoptosis in HT-29 colon adenocarcinoma cells. J. Clin. Invest., 96: 491-503, 1995.
46. Pitot, H. C. The molecular biology of carcinogenesis. Cancer (Phila.), 72: 962-970, 1993.
47. Ho, S. B., Niehans, G. A., Lyftogt, C., Van, P. S., Cherwitz, D. L., Gum, E. T., Dahiya, R., and Kim, Y. S. Heterogeneity of mucin gene expression in normal and neoplastic tissues. Cancer Res., 53: 641-651, 1993.
48. Wright, S. C., Zhong, J., and Larrick, J. W. Inhibition of apoptosis as a mechanism of tumor promotion. FASEB J., 8: 654-660, 1994.
49. Tsujii, M., and DuBois, R. N. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell, 83: 493-501, 1995.